Lobby Spends $59M on Search Ads Over Drug Costs

Advertising teams should note that paid search can be used for issue advocacy as well as product sales.

Updated on Nov. 5, 2026 in Advertising

Lobby Spends $59M on Search Ads Over Drug Costs

Live Poll

Do you trust drug industry advertising about why prescription prices are high?

The U.S. pharmaceutical lobbying group PhRMA spent an estimated $59 million on search advertising over seven years, aimed at shaping how Americans view prescription drug costs. For advertisers and marketers, the campaign shows how paid search can be used for issue advocacy rather than product sales.

Why it matters

The spending surged around legislative and regulatory actions, including the start of Medicare drug price negotiations in 2023, suggesting the campaign was timed to policy moments rather than run continuously. The findings come from a new analysis modeling the search spend, which points to how keyword targeting can be used to direct audiences toward specific viewpoints.

The estimated $59 million in search advertising breaks down to roughly $32 million on insurance and health plan searches and roughly $28 million on pharmacy benefit manager criticism pages. The campaign used more than 283,500 distinct keywords and produced 17.1 million paid visits between 2019 and 2025.

The players

PhRMA

The Pharmaceutical Research and Manufacturers of America is the lobbying group for the U.S. pharmaceutical industry, representing major drug manufacturers in policy and public debate.

The details

Paid search works by bidding on keywords so that an advertiser's link appears when users search for those terms. PhRMA used this mechanism at scale, with more than 283,500 distinct keywords, to route people searching about insurance or prescription costs to web pages and domains with a particular message. The spending was modeled using data in a new analysis, which estimated the total at about $59 million across the period.

Timeline

  1. 2019 through 2025: PhRMA's paid search campaign generated 17.1 million visits.

  2. 2023: Medicare drug price negotiations began, and ad spending surged.

Market Landscape

Medicare drug price negotiations, which began in 2023, created a policy moment that the pharmaceutical lobby targeted with heightened search advertising. The campaign shows industry groups using paid search as an issue-advocacy channel alongside traditional lobbying.

Marketing teams should note that paid search can be deployed for issue advocacy and policy messaging, not only product sales. Businesses that rely on search advertising should monitor how keyword targeting and political messaging intersect when setting budgets and reviewing compliance.

The takeaway

Paid search can reach large audiences quickly and at scale, so advertising teams should understand how issue-focused campaigns use the same tools as product marketing. Review search ad disclosure and compliance practices with qualified counsel before committing budget to politically sensitive keywords.

Further reading

For related coverage, explore the Advertising section on how paid search is used across industries.

Source note: This article includes information reported by STAT.

Live Poll

Do you trust drug industry advertising about why prescription prices are high?